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Abstract
Background—Increasing knowledge about HPV and HPV vaccine is a potentially important
way to increase vaccination rates, yet few education interventions have addressed these topics. We
report the results of an education intervention targeting three key groups who have contact with
adolescent females.
Methods—We conducted HPV education intervention sessions during 2008 and 2009 in
Guilford County, North Carolina. Parents (n=376), healthcare staff (n=118), and school staff
(n=456) attended the one-time sessions and completed self-administered surveys. Analyses used
mixed regression models to examine the intervention’s effects on participants’ self-rated HPV
knowledge, objectively assessed HPV and HPV vaccine knowledge, and beliefs about HPV
vaccine.
Results—Participants had relatively low levels of objectively assessed HPV and HPV vaccine
knowledge prior to the intervention. The education intervention increased self-rated HPV
knowledge among all three key groups (all p<0.001), as well as objectively assessed knowledge
about many aspects of HPV and HPV vaccine among healthcare and school staff members (all
p<0.05). Following the intervention, over 90% of school staff members believed HPV and HPV
vaccine education is worthwhile for school personnel and that middle schools are an appropriate
venue for this education. Most parents (97%) and school staff members (85%) indicated they
would be supportive of school-based vaccination clinics.
Conclusions—Our education intervention greatly increased HPV and HPV vaccine knowledge
among groups influential to the HPV vaccination behaviors of adolescent females.
Impact—Education interventions represent a simple yet potentially effective strategy for
increasing HPV vaccination and garnering stronger support for school-based vaccination clinics.
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Introduction
Guidelines currently recommend that 11–12 year old females receive the 3-dose regimen of
human papillomavirus (HPV) vaccine, with catch-up vaccination for 13–26 year old females
(1). Widespread vaccination may greatly reduce cervical cancer incidence, perhaps by as
much as 77% (2), as well as anal cancer incidence (3). However, recent data suggest fewer
than half of 13–17 year old females in the United States (US) have received 1 or more doses
of HPV vaccine, and only 32% have completed the 3-dose regimen (4).
Parents, healthcare providers, and school staff members are key stakeholders in the HPV
vaccination behaviors of adolescent females. Parents are typically the main decision makers
in choosing whether their adolescent daughters receive HPV vaccine (5). Healthcare
providers are also important, since most females receive HPV vaccine at doctors’ offices (6)
and provider recommendation is a key determinant of HPV vaccine uptake (7–9). Teachers
and school administrators are likely to play an increasingly important role in influencing
whether adolescent females receive HPV vaccine. School-based HPV vaccination programs,
which have been exceptionally effective in Australia and the United Kingdom (10–12), have
now started to expand to the US (13). Few schools in the US, however, currently provide
vaccines of any type to students (14), likely because of issues concerning billing, insurance,
and costs to the schools.
It is critical that key stakeholders possess adequate knowledge about HPV and the vaccine.
Knowledge is important in the early stages of behavior change according to multiple
frameworks that characterize the stages of adoption of health behaviors (15, 16).
Furthermore, adequate knowledge is a prerequisite for making informed decisions about
vaccination and vaccine policies. For this reason, providing information (to improve
knowledge) is a common component of behavioral interventions (17).
Despite the role knowledge may play in HPV vaccination behaviors, several studies have
shown HPV knowledge to be relatively low among parents and adult women in the US (18–
21). Parents have also indicated that one of the main reasons why their daughters have not
received HPV vaccine is a lack of information or knowledge about HPV and the vaccine (9,
22, 23). Many physicians and nurses in the US lack knowledge about certain aspects of HPV
and HPV vaccine as well (24–27). We were not able to locate any studies examining HPV
knowledge among school faculty and administrators. In addition to actual knowledge about
HPV and the vaccine, it is important that these stakeholders have high levels of self-rated
knowledge so that they feel confident discussing HPV vaccine with adolescent females and
making informed decisions regarding vaccination.
Given inadequate HPV and HPV vaccine knowledge, education interventions designed to
improve knowledge levels represent a potentially important initial step toward increasing
vaccination rates among adolescent females. Such interventions may also influence
individuals’ beliefs and attitudes about HPV vaccination, such as the acceptability of school-
based HPV vaccination programs. Only a few intervention studies, however, have been
conducted, all of which demonstrated that simple strategies (e.g., providing written materials
or verbal information) improved knowledge among parents, adult women, or students (28–
33). To the best of our knowledge, no studies have assessed the effectiveness of education
interventions among healthcare providers or school employees. In this report, we describe
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the results of an HPV and HPV vaccine education intervention targeting three key groups
who have contact with adolescent females: parents, healthcare staff, and school staff
members. Results provide valuable information for future programs designed to increase not
only knowledge about HPV and HPV vaccine but also vaccination rates.
Materials and Methods
Participants and recruitment
The Guilford County HPV Campaign sought to create a model for school-based HPV
vaccination programs through collaborative partnerships between the local school system
and local health department. Guilford County, North Carolina has the potential to benefit
greatly from HPV vaccination since its cervical cancer mortality rate is among the highest in
the state (6.1 deaths per 100,000 women annually) (34). A year prior to the launch of the
school HPV vaccination campaign in Guilford County (results of which we report separately
(35)), we conducted an HPV education campaign called “Don’t Wait….Educate!”. The
campaign consisted of education intervention sessions throughout the county that targeted
caregivers of middle school students (referred to as “parents”), nurses and health educators
(referred to as “healthcare staff”), and school administration and faculty members (referred
to as “school staff”). We conducted this initial phase of the project to increase knowledge
about HPV and HPV vaccine among key groups who have contact with adolescent females,
the target population for HPV vaccination. To assist with intervention development and
implementation, we formed an advisory team comprised of individuals from the Guilford
County Department of Public Health, the local school system, and the community.
After gaining approval from appropriate members of the Guilford County School System,
we began conducting education sessions in middle schools. In participating schools, we held
separate sessions for parents and school staff, which commonly occurred in locations such
as the school library or media room. To reach a greater number of parents, we conducted
additional sessions on-site at various community events and sites. Parent sessions were open
to anyone interested in attending. For healthcare staff, we held education sessions for school
health nurses, congregational nurses, student nurses, community health educators, and
various professional medical societies. We also conducted an education session at the
Guilford County Department of Public Health for all interested healthcare workers in the
community. All education sessions occurred during 2008 and 2009.
To increase attendance at the education sessions, we developed a marketing and publicity
plan to promote the sessions. We held many of the events outside of normal business hours
or on weekends, and we held sessions for school staff during mandatory staff meetings.
School websites and voicemail systems helped notify and remind parents about the
education sessions. Participants did not receive incentives for attending a session. We report
data from 118 healthcare staff members (from 5 education sessions), 456 school staff
members (from 11 education sessions), and 376 parents (from 16 education sessions),
excluding data for 5 healthcare staff members and 25 school staff members who did not
complete both pre- and post-intervention surveys.
Intervention
We developed an educational PowerPoint presentation on HPV and HPV vaccine that
provided information on HPV prevalence and transmission, diseases associated with HPV
infection, vaccine recommendations, dosage schedule, vaccine efficacy and safety, and
insurance coverage for the vaccine. The presentation lasted about 30–40 minutes including
time for questions. A community health educator who was part of the advisory team gave
the presentations. We also developed an educational handout to accompany the presentation
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that had similar information. We instructed participants from all three groups to refrain from
using the educational handout when completing surveys. School and healthcare staff
members completed self-administered written surveys both before and after the education
intervention. Pre-intervention surveys were distributed, completed, and collected prior to
presentations, and post-intervention surveys were distributed and completed following
presentations. Based on advisory team members’ advice that multiple surveys may
discourage parents’ participation, we asked parents to complete surveys only following
presentations.
Measures
We designed the surveys mainly to assess participants’ knowledge about HPV and HPV
vaccine (items shown in Table 1). To reduce respondent burden, we omitted some items for
some groups. We asked participants to rate their knowledge of HPV from 1 to 10, with 10
being the highest level (i.e., self-rated knowledge). Both pre- and post-interventions surveys
contained this item for school and healthcare staff members. On parents’ post-intervention
surveys, they rated their current knowledge and estimated their knowledge before the
educational presentation. School and healthcare staff surveys (pre- and post-intervention)
contained multiple choice items regarding the number of new HPV cases diagnosed each
year in the US (about 6 million), the percent of these cases that occur in 15–24 year olds
(74%), and the percent of cervical cancer cases in which HPV can be found (99%) (36). For
each item, we scored responses as “correct” or “incorrect”.
School and healthcare staff surveys (pre- and post-intervention) also included true/false
items about HPV and the vaccine. We asked healthcare staff members whether: 1) a woman
in the US dies every 2.5 hours from cervical cancer (true); 2) vaccinated females no longer
need to receive regular Pap smear tests (false); 3) HPV vaccine has shown virtually 100%
efficacy in preventing HPV infection among virus-naïve females but does not protect against
or treat existing HPV infections (true); and 4) half of women diagnosed with cervical cancer
between the ages of 35 and 50 were mostly likely exposed to HPV in their teens or early
twenties (true). School staff surveys only included the last two true/false items. The
presentation and handout provided information needed to correctly answer the items.
The surveys also assessed beliefs surrounding HPV vaccine, education programs, and
school-based vaccination clinics. We asked school staff (pre- and post-intervention) if they
believed HPV and HPV vaccine education is worthwhile for school personnel (yes or no),
whether middle schools are an appropriate venue for this education (yes or no), and what
they would do if a student approached them with questions about HPV or the vaccine. For
the last item, response options included: 1) feel comfortable or confident enough in their
knowledge about HPV to talk with the student themselves; 2) advise the student to speak
with the school nurse; 3) advise the student to speak with a parent; and 4) tell the student
they are too young to be concerned with such things. We allowed participants to select more
than one answer for this item. We asked school staff (pre- and post-intervention) and parents
(post-intervention) if they would be supportive of school-based vaccination clinics.
Healthcare staff surveys (pre- and post-intervention) assessed whether they believed
community education on HPV and HPV vaccine is valuable and whether they would choose
to vaccinate their daughter if they had one in the approved age range for HPV vaccine. We
collected data on gender, age, and race/ethnicity for all three groups, as well as occupation
for healthcare staff members.
Data analysis
For all groups, we compared pre- and post-intervention self-rated HPV knowledge. For
healthcare and school staff, we compared pre- and post-intervention objectively assessed
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HPV knowledge and beliefs regarding HPV and HPV vaccine. We also compared self-rated
HPV knowledge across the three groups, using the Bonferroni correction to account for
multiple comparisons. We used mixed regression models for analyses as participants were
clustered within education sessions. Data were analyzed with SAS Version 9.2 (Cary, NC)
using two-tailed statistical tests and a critical alpha of 0.05.
Results
Healthcare staff
About 60% of healthcare staff members were health educators, and just over 40% were
nurses. Most were female (93%), older than 40 years of age (58%), and non-Hispanic white
(50%) or non-Hispanic African American (46%) (Table 2). Healthcare staff members
indicated much higher levels of self-rated HPV knowledge on their post-intervention
surveys (mean=8.12, SD=1.09) compared to their pre-intervention surveys (mean=5.69,
SD=2.01, p<0.001) (Figure 1). The education intervention substantially increased staff
members’ objectively assessed knowledge about HPV and HPV vaccine (Table 3).
Compared to pre-intervention surveys, more staff members indicated on their post-
intervention surveys that there are about 6 million new HPV cases in the US each year (31%
vs. 85%, p<0.001), that 74% of these new cases occur among 15–24 year olds (59% vs.
95%, p<0.001), that HPV can be found in 99% of cervical cancer cases (20% vs. 84%,
p<0.001), that HPV vaccine will not protect against or treat existing infections (77% vs.
97%, p<0.001), and that a woman dies every 2.5 hours from cervical cancer in the US (77%
vs. 87%, p<0.05).
Healthcare staff members tended to hold positive beliefs about HPV vaccine. Most would
choose to vaccinate their daughters against HPV if they were in the vaccine’s approved age
range (pre=86%, post=91%, p=0.21) and thought community education on HPV and HPV
vaccine is valuable (pre=98%, post=100%, p value could not be calculated) (Table 4).
School staff
Most school staff members were female (77%), 40 years of age or younger (57%), and non-
Hispanic white (68%). About a quarter were non-Hispanic African American (27%) (Table
2). School staff members rated their HPV knowledge higher following the intervention
(mean=7.36, SD=1.79) than before (mean=4.75, SD=2.36, p<0.001) (Figure 1). The
education intervention also increased the proportion of staff members who answered HPV
knowledge items correctly (Table 3). Compared to pre-intervention surveys, more staff
members responded correctly following the intervention that there are about 6 million new
HPV cases in the US each year (38% vs. 87%, p<0.001), that 74% of these new cases occur
among 15–24 year olds (51% vs. 89%, p<0.001), that HPV can be found in 99% of cervical
cancer cases (12% vs. 69%, p<0.001), that HPV vaccine will not protect against or treat
existing infections (78% vs. 97%, p<0.001), and that half of cervical cancer cases between
ages 35–50 were exposed to HPV in their teens or early twenties (92% vs. 98%, p<0.001).
Although school staff members tended to support HPV education and vaccination programs
prior to the intervention, a higher proportion believed post-intervention that HPV and HPV
vaccine education is worthwhile for school personnel (80% vs. 91%, p<0.001), that middle
schools are an appropriate venue for such education (86% vs. 91%, p<0.05), and would be
supportive of school-based vaccination clinics (79% vs. 85%, p<0.05) (Table 4). More
school staff members reported after the intervention that they felt comfortable or confident
enough in their knowledge to talk about HPV if approached by a student (14% vs. 42%,
p<0.001), and about the same proportion would advise the student to talk with a parent (32%
vs. 33%, p=0.60). After the intervention, fewer would need to refer the student to the school
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nurse (77% vs. 57%, p<0.001). Only two staff members indicated on their pre-intervention
surveys they would tell the student they are too young to be concerned with such things;
none indicated this on post-intervention surveys.
Parents
Most parents were female (91%), 40 years of age or younger (51%), and non-Hispanic white
(44%) or non-Hispanic African American (49%) (Table 2). About 31% (115/354) of parents
indicated they had daughters who had already received at least one dose of HPV vaccine.
After the intervention, parents recalled having moderate self-rated knowledge about HPV
prior to the intervention (mean=5.69, SD=2.76); they offered higher self-ratings of their
HPV knowledge following the intervention (mean=8.76, SD=1.32, p<0.001) (Figure 1).
Most parents indicated they would be supportive of a school-based vaccination clinic (97%)
(Table 4).
Comparisons across groups
School staff members reported lower self-rated HPV knowledge on both pre- (compared to
both parents and healthcare staff) and post-intervention (compared to parents) surveys (all
p<0.05) (Figure 1). Self-rated knowledge among parents did not differ from that of
healthcare staff on pre- or post-intervention surveys (both p>0.05). While all groups
experienced an increase in self-rated knowledge, the largest increase was seen among
parents, with healthcare and school staff experiencing smaller increases (p<0.05).
Discussion
HPV vaccination rates among adolescent females in the US continue to lag behind other
developed countries (4, 10–12). Thus, it is important to implement intervention strategies to
improve vaccine uptake. Given relatively low HPV and HPV vaccine knowledge levels
observed among parents and healthcare providers (18–21, 24–27), education interventions
represent a simple and promising, yet underexplored, strategy. The few education
interventions conducted among parents, adult women, or students have produced
encouraging results (28–33), yet such interventions have not included other potentially
influential groups.
Similar to these past interventions (28–33), our education intervention increased actual HPV
and HPV vaccine knowledge levels among participants. For most knowledge items in our
surveys, higher proportions of healthcare staff and school staff members answered correctly
post-intervention compared to pre-intervention. Interestingly, the items most frequently
missed during pre-intervention surveys were similar for these two groups (i.e., knowing how
common HPV infections are, the age distribution of infections, and the percent of cervical
cancer cases where HPV can be found). Past studies have also shown that healthcare
providers often lack knowledge about some epidemiological aspects of HPV and HPV-
related disease (24, 27). Future education programs are needed for these groups, and a brief
education session may be sufficient to provide the necessary information about HPV and
HPV vaccine.
In addition to actual knowledge, our intervention also increased the self-rated knowledge
about HPV among parents, healthcare staff, and school staff. It is important that members of
these groups feel confident in making informed decisions regarding HPV vaccination.
Interestingly, school staff members tended to report lower self-rated knowledge compared to
parents and healthcare staff. As school-based HPV vaccination programs continue to
develop in the US (13), it becomes increasingly important to ensure that school staff
members feel (and are) knowledgeable about HPV and how it affects adolescents. To our
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knowledge, our study provides important initial insight into what this group currently knows
about HPV and HPV vaccine.
Following the intervention, over 90% of school staff members believed HPV and HPV
vaccine education is worthwhile for school personnel and that middle schools are an
appropriate venue for this education. Furthermore, about 85% would be supportive of a
school-based vaccination clinic, which is encouraging since school staff support is critical to
the success of any school-based vaccination program. In fact, one of the main lessons
learned from the few existing school-based HPV vaccination programs in the US is the
importance of forming an open and honest partnership with the school systems (13). Parents
were also very supportive of a school-based vaccination clinic following their education
sessions, which is consistent with our past research showing many mothers were willing to
get their adolescent daughters HPV vaccine at school (37). Taken together, our findings
suggest that having an education component as an initial part of school-based HPV
vaccination programs may garner even stronger support for the programs among parents and
school staff, two important stakeholders in determining the success of such programs. Future
research is needed to further examine the acceptability of school-based vaccination
programs, particularly among school staff, and what factors influence whether US schools
adopt such programs.
Our study had many strengths including focusing on three key groups important to
vaccinating adolescent females against HPV, using various strategies to increase attendance
at education sessions, and using an advisory team to assist with intervention development
and implementation. Limitations include conducting education sessions among convenience
samples in only one county in North Carolina, having relatively few male participants, and
not having physicians as part of the healthcare staff group. We also did not conduct a pre-
intervention survey for parents, instead asking them to self-rate their current HPV
knowledge and estimate their knowledge before the educational presentation on post-
intervention surveys. Some parents who completed surveys may not have had female
children in the approved age range for HPV vaccination, as these sessions were open to
anyone interested in attending. Since one-group pre- and post-study designs may overstate
effect sizes (38), it is important for future controlled studies to confirm our findings.
An important first step in increasing HPV vaccination rates among adolescent females in the
US is to improve knowledge levels among key groups influential to the adolescents’
vaccination behaviors. In this study, we demonstrated that a simple education intervention
greatly improved objectively assessed and self-rated HPV and HPV vaccine knowledge
levels among parents, healthcare staff, and school staff members. Such interventions offer a
relatively low effort and potentially effective strategy for increasing HPV vaccination.
Future research is needed to determine if education interventions affect vaccine uptake.
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Self-rated knowledge about HPV. Parents self-rated their current knowledge and estimated
their knowledge before the educational presentation in post-intervention surveys. Bars
indicate standard errors.
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Table 2
Characteristics of healthcare staff (n=118), school staff (n=456), and parents (n=376)
Healthcare Staff n (%) School Staff n (%) Parents n (%)
Gender
   Female 109 (93) 347 (77) 343 (91)
   Male 8 (7) 104 (23) 33 (9)
Age (Years)
   ≤40 49 (42) 253 (57) 190 (51)
   >40 67 (58) 191 (43) 181 (49)
Race / Ethnicity
   White, Non-Hispanic 57 (50) 300 (68) 166 (44)
   African American, Non-Hispanic 53 (46) 118 (27) 183 (49)
   Other 4 (4) 26 (6) 25 (7)
Occupation
   Nurse 48 (41) -- --
   Health Educator 70 (59) -- --
Note. Totals may be less than stated sample size due to missing data. Dashes (--) indicate item was not applicable.
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Table 3
HPV and HPV vaccine knowledge pre- and post-intervention (n correct / n total (%))
Healthcare Staff School Staff
Pre Post Pre Post
Number of new HPV cases each year in the USa 36/115 (31) 99/116 (85)** 169/445 (38) 393/452 (87)**
Percent of new HPV cases that occur in 15–24 year oldsa 69/117 (59) 111/117 (95)** 228/446 (51) 405/454 (89)**
Percent of cervical cancers where HPV can be founda 24/118 (20) 97/116 (84)** 54/443 (12) 311/450 (69)**
Vaccine is effective in virus-naïve females but does not protect against or
treat existing infections
90/117 (77) 113/117 (97)** 347/443 (78) 437/449 (97)**
Half of cervical cancer cases between ages 35–50 were likely exposed to
HPV in teens or early twenties
113/118 (96) 117/118 (99) 408/442 (92) 443/450 (98)**
A woman dies every 2.5 hours from cervical cancer in the US 91/118 (77) 103/118 (87)* -- --
Regular Pap smear tests are no longer needed after HPV vaccinationb 115/118 (97) 117/117 (100) -- --
Note. Analyses used mixed regression models since participants were clustered within education sessions. Sample sizes differ due to missing data.
Dashes (--) indicate item was not assessed.
a
Multiple choice item with responses scored as “correct” or “incorrect”. All other items used a true/false response scale.
b
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